Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v46-EN Version v36-EN
Language English English
Date Updated 2018-02-10 2018-01-26
Drug Identification Number 02272121 02272121
Brand name MYLAN-AMLODIPINE MYLAN-AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10.0MG 10.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT, 500BT 100BT, 500BT
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-01-31 2018-02-08
Actual start date 2018-01-31
Estimated end date 2018-02-09 2018-03-09
Actual end date 2018-02-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments